Monocyclic and bicyclic compounds and methods of use

Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are generally monocyclic and bicyclic compounds and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated diseases, and as controls i...

Full description

Saved in:
Bibliographic Details
Main Authors CHEN WEI, GREENMAN KEVIN LLOYD, ZHANG PENGLIE, PENNELL ANDREW M, LI LIANFA, WRIGHT JOHN J. K, SULLIVAN EDWARD J
Format Patent
LanguageEnglish
Published 22.03.2007
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are generally monocyclic and bicyclic compounds and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated diseases, and as controls in assays for the identification of competitive CCR1 antagonists.
AbstractList Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are generally monocyclic and bicyclic compounds and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated diseases, and as controls in assays for the identification of competitive CCR1 antagonists.
Author ZHANG PENGLIE
PENNELL ANDREW M
CHEN WEI
SULLIVAN EDWARD J
GREENMAN KEVIN LLOYD
LI LIANFA
WRIGHT JOHN J. K
Author_xml – fullname: CHEN WEI
– fullname: GREENMAN KEVIN LLOYD
– fullname: ZHANG PENGLIE
– fullname: PENNELL ANDREW M
– fullname: LI LIANFA
– fullname: WRIGHT JOHN J. K
– fullname: SULLIVAN EDWARD J
BookMark eNrjYmDJy89L5WQw8c3Py0-uTM7JTFZIzEtRSMqEcpLzcwvyS_NSisHCuaklGflAdn6aQmlxKg8Da1piTnEqL5TmZlB2cw1x9tBNLciPTy0uSExOzUstiQ8NNjIwMDcwMzO1MHY0NCZOFQDeyC9d
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2007066583A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2007066583A13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:25:33 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2007066583A13
Notes Application Number: US20060504215
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070322&DB=EPODOC&CC=US&NR=2007066583A1
ParticipantIDs epo_espacenet_US2007066583A1
PublicationCentury 2000
PublicationDate 20070322
PublicationDateYYYYMMDD 2007-03-22
PublicationDate_xml – month: 03
  year: 2007
  text: 20070322
  day: 22
PublicationDecade 2000
PublicationYear 2007
RelatedCompanies CHEMOCENTRYX, INC
RelatedCompanies_xml – name: CHEMOCENTRYX, INC
Score 2.673827
Snippet Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are generally monocyclic...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Monocyclic and bicyclic compounds and methods of use
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070322&DB=EPODOC&locale=&CC=US&NR=2007066583A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlILSt-JI03Z9KOL6wRD2gVtlb6P5GAxGO2yH-N97TVvd096SHCSXkF_uLpfcATxbwhao5xODCsbRQJGO4XJiGUKaTFDKrL7ymI7G9jCm7wtr0YJN8xdGxQn9VsEREVEc8V6o83r7f4kVqLeV-QtbY1P2Gs29QG-sY9y_hOjBwAunk2Di677vxTN9_FHRbBS35hvaSkelIl1G2g8_B-W_lO2-UInO4XiK_aXFBbRk2oFTv8m91oGTUe3yxmKNvvwSKAIw4z8cWdSSVGhsXVfKd-FleqRcNVdJoXMtW2m7XF7BUxTO_aGBwy__ZruMZ_u8mtfQTrNU3oBms54reN9xmbRpYroJde0Vyle3x6TpcHIL3UM93R0m38NZdW1pGoR0oV187eQDytuCPapl-gWnjoM8
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsXp1ILSt-JI03Z9GOLajar7wrWyt7F8DAbSDtsh_vde0073tLckB5dLyOXyuyR3AA-WsAWe84lBBeMIUKRjuJxYhpAmE5Qyq61uTIcjO4jo68yaVeBz-xdGxQn9VsERUaM46num9uv1vxPLV28r00e2wqbkqR92fH2LjnH9EqL73U5vMvbHnu55nWiqj94Lmo3m1nxGrHTgICjMI-33Prr5v5T1rlHpn8DhBPnF2SlUZFyHmrfNvVaHo2F55Y3FUvvSM6CogAn_4SiitoiFxlZlJX8XnqdHSlVzkRQ61ZKltknlOdz3e6EXGNj9_G-082i6K6t5AdU4ieUlaDZruYK3HZdJmy5Md0Fde4n21W0xaTqcNKC5j9PVfvId1IJwOJgPXkZv13BcuDBNg5AmVLOvjbxB25uxWzVlv_DOhic
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Monocyclic+and+bicyclic+compounds+and+methods+of+use&rft.inventor=CHEN+WEI&rft.inventor=GREENMAN+KEVIN+LLOYD&rft.inventor=ZHANG+PENGLIE&rft.inventor=PENNELL+ANDREW+M&rft.inventor=LI+LIANFA&rft.inventor=WRIGHT+JOHN+J.+K&rft.inventor=SULLIVAN+EDWARD+J&rft.date=2007-03-22&rft.externalDBID=A1&rft.externalDocID=US2007066583A1